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Aim: To assess the role of the young radiation oncologist in the context of important recent
advancements in the ﬁeld of radiation oncology, and to explore new perspectives and com-
petencies of the young radiation oncologist.
Background: Radiation oncology is a ﬁeld that has rapidly advanced over the last century. It
holds a rich tradition of clinical care and evidence-based practice, and more  recently has
advanced with revolutionary innovations in technology and computer science, as well as
pharmacology and molecular biology.
Materials and methods: Several young radiation oncologists from different countries evaluated
the current status and future directions of radiation oncology.
Results: For young radiation oncologists, it is important to reﬂect on the current practice
and  future directions of the specialty as it relates to the role of the radiation oncologist in
the  comprehensive management of cancer patients. Radiation oncologists are responsible
for  the radiation treatment provided to patients and its subsequent impact on patients’
quality of life. Young radiation oncologists must proactively master new clinical, biological
and  technical information, as well as lead radiation oncology teams consisting of physicists,
dosimetrists, nurses and technicians.
Conclusions: The role of the young radiation oncologist in the ﬁeld of oncology should beproactive in developing new competencies. Above all, it is important to remember that we
are  dealing with the family members and loved ones of many individuals during the most
difﬁcult part of their lives.
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1.  Background
Radiation therapy has been in use for the treatment of can-
cer and other diseases for approximately 100 years. As early
as 1897, it was concluded that X-rays could be used for ther-
apeutic as well as diagnostic purposes, and in 1912, Marie
Curie published the Theory of Radioactivity. The investiga-
tion of X-ray radiation for patient therapy moved into clinical
practice in the early 1920s.1 Since the ﬁrst uses of radiation
to treat cancer, important changes and advancements have
occurred,2–5 including: (1) the generation of higher energy
radiation beams from linear accelerators; (2) the use of com-
puted tomography (CT), positron emission tomography (PET),
magnetic resonance (MR), and other image  data sets to cre-
ate three-dimensional planning models to accurately guide
treatment; (3) the development of new radiation techniques,
such as intensity modulated radiation therapy (IMRT), image
guided radiation therapy (IGRT), robotic radiosurgery and pro-
ton therapy; (4) the implementation of new molecular targeted
therapies; (5) an increase in the multidisciplinary treatment
of cancer; and (6) a greater emphasis on high-quality research
and evidence-based care.6–8
2.  Aim
The focus of the current article is to investigate the role of the
young radiation oncologist in the context of these important
advancements, and to explore new perspectives and compe-
tencies of the young radiation oncologist.
3.  Materials  and  methods
Several young radiation oncologists from different countries
evaluated the recent advancements and the current status
of the ﬁeld of radiation oncology, providing new perspec-
tives about the role of the young radiation oncologist. A
young radiation oncologist was deﬁned as having ten or
fewer years of clinical practice in Radiation Oncology. To pro-
vide a broad range of perspectives, the contributions from
four young radiation oncologists from four different countries
(United States, Chile, France, and Spain) were included in this
article. Three of them are members of a national young radi-
ation oncology group (i.e. Spanish young radiation oncology
group [SYROG]).9–11 The four participants agreed to focus on
two topics that currently affect the daily work activities: the
implantation of novel technology in the radiation oncology
departments and the new competencies developed within a
multidisciplinary group. All of them contributed to this report
with their own thoughts and experiences.
4. Results
4.1.  Technology  and  radiation  therapyInterestingly, the media present this subject as a major
recent ‘breakthrough’ in treatment, largely by demonstrat-
ing aspects of technology itself.12 Yet we know that since theiotherapy 1 7 ( 2 0 1 2 ) 251–254
discovery of ionizing radiation, the clinical practice of radia-
tion oncology has beneﬁted tremendously from a long string
of discoveries and innovations in physics and technology. One
of the major problems that is not often highlighted is that
high-tech therapy is often associated with a high cost and,
therefore, is not always widely available.13 The young radia-
tion oncologist should have an understanding of the rational
use of new technologies based on scientiﬁc evidence of its
cost-effective contribution to cancer management. In broader
terms, the cancer profession and technology industry should
take responsibility by not accepting substandard evidence of
marginal beneﬁt without regard for cost. More  work is needed
to demonstrate true value from new technologies and the cost-
effectiveness of emerging new treatments.14
In addition, major changes in radiation treatment planning
have occurred with advances in functional imaging, especially
PET and nuclear MR spectroscopy which are of great value in
the planning of radiation therapy, allowing us to deﬁne with
greater precision the target volume. With more  sophisticated
imaging and understanding of normal tissue and anatomy,
the young radiation oncologist will need more  detailed under-
standing of which constraints are essential and which are
desired.15–17
Regarding treatment delivery, image  guidance in radiation
treatment is not a novel concept, and remains of major impor-
tance today. For many  years, radiation ﬁeld placement was
veriﬁed using portal ﬁlms and, more  recently, electronic por-
tal images. However, these modes of imaging are limited to
visualizing high-contrast matter in 2-dimensional views. This
concept has now evolved into IGRT and volumetric soft-tissue
imaging at the time of treatment.17 The cone beam CT, which
consists of a kV X-ray tube mounted on a linear accelerator,
has the potential to reduce setup errors and, hence, planning
tumor volumes. This, in turn, permits potential delivery of
hypofractionated regimens to small tumors with greater accu-
racy. Investigation of adaptive therapy and online planning is
also possible as a result of these technological advances.17,18
Perhaps the most attractive feature of these advancements
in technology is the ability to now approach any complex
tumor geometry, regardless of shape, with an enhanced ability
to optimize the dose distribution. Much of the excitement sur-
rounding new advances in radiation technology stems from
this concept of dose-escalation. Theoretically, increasing radi-
ation dose should lead to improvements in local control.
Studies have shown that CT-based planning and IGRT are asso-
ciated with reduced dose rate to surrounding normal tissues
and a subsequent reduction in serious grade 3 or greater acute
morbidity.12 The real question is what proportion of patients
will truly beneﬁt from techniques beyond “conventional”
treatment. The cost-effectiveness of these sophisticated radi-
ation therapy methods depends on our ability to identify
which patients are at higher risk of locoregional relapse and
more likely to beneﬁt from dose-escalation. Not only would
this improve the cost-effectiveness ratio, but also improve the
individual patient’s therapeutic gain.13
Ideally, the specialist’s training period of the young radi-
ation oncologist should include learning about these new
techniques in radiation planning and treatment. Residents
should have the opportunity to visit other institutions, if their
cancer center does not offer this type of technology, in order
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o learn how it works, as well as to see its potential beneﬁts
nd indications.19
.2.  Role  of  the  young  radiation  oncologist:  developing
ew competencies
etween 2010 and 2020, the total number of patients receiv-
ng radiation therapy during their initial treatment course
s expected to increase by 22% in the United States (US). In
ontrast, assuming that the current graduation rate of 140
esidents per year remains constant, the number of full-time
quivalent radiation oncologists is expected to increase by
nly 2%. Therefore, demand for radiation therapy is expected
o grow 10 times faster than supply between 2010 and 2020
n the US.20 For the young radiation oncologist, it is impera-
ive to explore strategies to enhance capacity to deliver quality
adiation therapy and meet the increase in patient load. In
ddition, the young radiation oncologist must master all the
ew clinical, biological, and technical information necessary
o comprehensively care for the cancer patient. The young
adiation oncologist must be competent in all relevant clinical
spects of cancer treatment, have a good understanding of the
ndications for cytotoxic and molecular therapies, and be thor-
ughly familiar with the technical aspects of radiotherapy.21
As young radiation oncologists, we  are responsible for the
adiation treatment delivered to our patients and its sub-
equent impact on their quality of life. Therefore, in our
mpathic dealings with our patients, we must be aware of
he various psychosocial factors that inﬂuence their outcome.
his comprehensive approach to cancer care should underlie
ur leadership of the radiation oncology team. The delivery
f radiation therapy requires a coordinated, many-membered
eam consisting of radiation oncologists, radiation therapists
including dosimetrists and other planning experts), medi-
al physicists and administrative, engineering, computer, and
nformation technology specialists.17 We  have also a critical
ole in leading this team.
Additionally, we must be well regarded clinicians within a
ultidisciplinary group.22 We must be articulate spokesmen
n the selection of therapy, management of treatment-related
orbidity, and careful follow-up of our patients. We  must
romote collaboration and exchange with other departments
nd augment the teaching environment in order to improve
he quality of our practice for the beneﬁt of our patients.
he professional education of radiation medicine practition-
rs plays a major role in our ability to provide high quality
are to cancer patients and to meet society’s expectations.
igher education prepares students for these roles, but formal
nd informal professional education in health care contin-
es throughout their working life. Medical knowledge, skills,
nd priorities constantly change, and keeping abreast of new
evelopments cannot be a matter of chance. With a constantly
hanging practice, the links between higher education and
ractice must be dynamic and strong, so that professional edu-
ation remains relevant to practice needs, and trainees are
dequately prepared for clinical practice.New developments in our understanding of cancer have
hanged the practice in radiation treatment facilities. When
reatment methods change, the profession’s knowledge
nd skills change, and practitioners must develop newtherapy 1 7 ( 2 0 1 2 ) 251–254 253
competencies. The organization of the practice also
adapts and responds to the new challenges.17,23
Current radiation medicine practice is difﬁcult to cap-
ture. It is constantly evolving in response to rapid
changes in the discipline and varies according to
regulatory jurisdictions and individual institutional
practices.
Radiation oncology is a textbook example of applied or
translational research. Evidence-based medicine has been
deﬁned as “. . .the conscientious, explicit and judicious use
of current best evidence in making decisions about the care
of individual patients”.24 Radiation oncology is increasingly
evidence-based,25 with a number of large randomized trials of
good methodologic quality published in the past years, a num-
ber of trials open for accrual, and new trials currently being
developed.
The Young Scientists’ Forum organized by the Greater
Poland Cancer Centre26 is an excellent example of the pro-
motion of scientiﬁc research. This Forum is dedicated to the
development of scientiﬁc research projects of young radiation
oncologists, medical physicists and radiobiologists in Poland.
The major aim of the Forum is to present results of current
scientiﬁc projects under development. The presented work is
evaluated by the specialists in the ﬁeld of radiotherapy, med-
ical physics and radiobiology.
Other prime examples are the European young radia-
tion oncology societies based in Spain9 and France.10 The
main objective of these groups is to motivate young spe-
cialists and promote scholarly activity in national and
international meetings. These societies also promote under-
standing among young specialists of the importance of
receiving adequate training according to international stan-
dards (European Organization for Research and Treatment of
Cancer [ESTRO] Fellow Program). In addition, these groups
instigate and help young specialists to obtain interna-
tional training and potentially set up new national and
international protocols in the ﬁeld of radiation oncol-
ogy.
The Association of Residents in Radiation Oncology (ARRO)
is an organization11 based in the United States that is
dedicated to promoting the ongoing education of trainees
in Radiation Oncology through journal clubs, workshops,
and networking opportunities. By providing consolidated
resources for a variety of research funding opportunities and
fellowships, it supports the scholarship of its members. It
also serves to formalize residents’ input into professional
organizations, including the American Society for Radiation
Oncology (ASTRO).
As with other groups created in past years,27 there is no
reason why young researchers should not be at the forefront
of research and publication. This will be possible when young
investigators apply their knowledge, skills, and resources
in a manner that is focused and constructive. Including a
speciﬁc program focus in clinical trial research methodol-
ogy during residency would encourage young professionals
to initiate high-quality, prospective research. The opportu-
nity to provide academic leadership on an international scale
is available, but it is up to us to seize the opportunity, to
expand our horizons, and to proceed with energy, passion, and
conviction.
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5.  Conclusions
In summary, education and training in radiation oncology
should be based on sound educational principles and early,
comprehensive experience. Learning formats should be tai-
lored to speciﬁc needs and emphasis given to collaborative
and team-based methods that are required in the multidis-
ciplinary environment. We agree with Dr. Zietman,28 current
president ofASTRO, that if radiation oncologists become sim-
ply the guardians of a single therapeutic modality, they may
ﬁnd that time marches by and, while the techniques will live
on, the specialty may not. As young radiation oncologists,
we see new challenges in our clinical practice in this con-
stantly and rapidly evolving ﬁeld. By keeping up with the
constant ﬂow of new information that comes through scien-
tiﬁc conferences and peer-reviewed publications, as well as
the development of new technologies, we  will be able to treat
our patients more  effectively and safely. Our role in the ﬁeld of
oncology should be proactive, and above all, we must remem-
ber that we  are dealing with the family members and loved
ones of many  individuals during the most difﬁcult part of their
lives.
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